Best Known For
first approved by the U.S. Food and Drug Administration (FDA) on January 8, 2014
Core Claims
- Dapagliflozin was first approved by the U.S. FDA on January 8, 2014 for type 2 diabetes.
- Approval timelines can differ by regulator across the EU, UK, or other jurisdictions.
- The initial FDA approval for dapagliflozin in 2014 was for type 2 diabetes.
Differentiators
Pricing Perception:
Not Mentioned